| 000 | 01769nam a2200217Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20260718102836.0 | ||
| 008 | 230508s2022 xx 000 0 und d | ||
| 050 |
_aAllied HD 9665.5 _bK48 2022 |
||
| 100 | 1 | _aMoorman, Mike | |
| 245 | 1 | 0 |
_aKey account management excellence in pharma & medtech / _cMike Moorman. |
| 264 |
_aLondon : _bRoutledge, _c2022. |
||
| 300 |
_axxv, 216 pages ; _c24 cm. |
||
| 500 | _aIncludes index | ||
| 505 | 0 | _ach. 1. Kam is a business strategy, not a role — ch. 2. The rise of the organized customer and kam in healthcare — ch. 3. Where to play: key account segmentation and selection — ch. 4. Value strategy: evolving from basic offerings to advanced solutions — ch. 5. Kam organization design: form follows function — ch. 6. Executive alignment and engagement: its make or break for life sciences kam program — ch. 7. Kam program office: marshalling the internal support required for results — ch. 8. The long and short of kam matrics — ch. 9. Customer engagement process: the secret to agile execution — ch. 10. Bringing value to account planning and management — ch. 11. Context is king: laying the foundation for a comprehensive kam talent strategy — ch. 12. The unique learning journey required for kam — ch. 13. Key account manager incentive compensation: aligning to strategic objectives — ch. 14. Why technology is critical for breathing life into kam — ch. 15. Kam in the United States versus Europe: are we headed to the same place? — ch. 16. The future of kam in life science. | |
| 650 | 0 |
_aPharmaceutical industry _xManagement |
|
| 650 | 0 | _aMedical supplies industry | |
| 650 | 0 |
_aMarketing _xKey accounts |
|
| 650 | 0 | _aCustomer services | |
| 942 |
_2lcc _cBK _kEAC Cavite-Allied |
||
| 999 |
_c33454 _d33454 |
||